Mayne Pharma Group Limited announced that Mr. David Petrie has accepted an invitation to join the Board of Mayne Pharma, effective 1 September 2022. The Company announced that Mr. Ian Scholes, Deputy Chair will retire from the Board at the end of September 2022. Mr. Petrie is an accomplished M&A executive with over 30 years of advisory experience in public and private mergers and acquisitions, capital management and debt and equity raisings. He is currently Principal at Stratford Advisory Group, an independent corporate and financial advisory firm. Previously, he spent 23 years at Merrill Lynch/Bank of America including Managing Director and Head of Investment Banking Melbourne. He has worked on more than 100 transactions across a range of market sectors including healthcare. Mr. Scholes has served as a Director of Mayne Pharma since October 2007 and is currently the Chair of the Audit and Risk Committee and a member of the Remuneration and People Committee and Nomination Committee. Mr. Petrie has a Bachelor of Commerce (Honours) and Bachelor of Law (Honours) from the University of Melbourne. He has been a CPA for 30 years and is admitted as Barrister and Solicitor
of the Supreme Court of Victoria. Mr. Petrie will also join Mayne Pharma's Audit and Risk Committee and the Remuneration and People Committee.